Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine

Sarah Ducamp, Anoop K. Sendamarai, Dean R. Campagna, Desmond Wai Loon Chin, Yuko Fujiwara, Paul J. Schmidt, Mark D. Fleming

Blood (2024) 144 (13): 1418–1432.

https://doi.org/10.1182/blood.2023023078

Published: 2024

Includes: Supplemental data

Journal Articles

Bitopertin, a Selective Glycine Transporter 1 Inhibitor, Reduced Protoporphyrin IX (PPIX) Level and Improved Liver Fibrosis in a Mouse Model of Erythropoietic Protoporphyria (EPP)

Min Wu, Sarah Ducamp, Yi Xiang, Juan Putra, Mark D. Fleming, Brian MacDonald, Paul J Schmidt

Blood (2022) 140 (Supplement 1): 8192–8193.

https://doi.org/10.1182/blood-2022-168924

Published: 2022

Journal Articles

Pyridoxine Response in Mouse Alas2 Knock-in Models of X-Linked Sideroblastic Anemia and X-Linked Protoporphyria

Sarah Ducamp, Paul J Schmidt, Dean R Campagna, Mark D. Fleming

Blood (2021) 138 (Supplement 1): 925.

https://doi.org/10.1182/blood-2021-150683

Published: 2021

Journal Articles

A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia

Daniel A. Lichtenstein, Andrew W. Crispin, Anoop K. Sendamarai, Dean R. Campagna, Klaus Schmitz-Abe, Cristovao M. Sousa, Martin D. Kafina, Paul J. Schmidt, Charlotte M. Niemeyer, John Porter, Alison May, Mrinal M. Patnaik, Matthew M. Heeney, Alec Kimmelman, Sylvia S. Bottomley, Barry H. Paw, Kyriacos Markianos, Mark D. Fleming

Blood (2016) 128 (15): 1913–1917.

https://doi.org/10.1182/blood-2016-05-719062

Published: 2016

Includes: Supplemental data

Journal Articles

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

Blood (2015) 126 (25): 2734–2738.

https://doi.org/10.1182/blood-2015-09-659854

Published: 2015

Includes: Supplemental data

Journal Articles

A Novel Conditional Knockout of the Diamond Blackfan Anemia Gene Rpl11 Shows Failure of Erythropoiesis, a Marked Increase in BFU-E Progenitors By Phenotype That Proliferate Poorly in Culture, and Activation of p53 Target Genes

Cailin E Joyce, PhD, Meaghan McGuinness, BS, Rebekka K Schneider, MD, Mark D. Fleming, MD DPhil, Dean R Campagna, BS, Paul J Schmidt, PhD, Benjamin L Ebert, MD PhD, Carl D. Novina, MDPhD, Colin A. Sieff, MB.BCh

Blood (2015) 126 (23): 1205.

https://doi.org/10.1182/blood.V126.23.1205.1205

Published: 2015

Journal Articles

Mutant Splicing Factor 3b Subunit 1 (SF3B1) Causes Dysregulated Erythropoiesis and a Stem Cell Disadvantage

Esther A. Obeng, MDPhD, Marie E. McConkey, PhD, Dean Campagna, Rebekka K. Schneider, MD, Michelle C. Chen, Paul J Schmidt, PhD, Ann Mullally, MD, Mark D. Fleming, MD DPhil, Benjamin L. Ebert, MD DPhil

Blood (2014) 124 (21): 828.

https://doi.org/10.1182/blood.V124.21.828.828

Published: 2014

Journal Articles

HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression

Xing-gang Wu, Yang Wang, Qian Wu, Wai-Hang Cheng, Wenjing Liu, Yueshui Zhao, Claire Mayeur, Paul J. Schmidt, Paul B. Yu, Fudi Wang, Yin Xia

Blood (2014) 124 (8): 1335–1343.

https://doi.org/10.1182/blood-2014-01-552281

Published: 2014

Includes: Supplemental data

Journal Articles

An RNAi-Therapeutic Targeting Tmprss6, in Conjunction With Oral Chelator Therapy, Ameliorates Anemia and Additively Diminishes Secondary Iron Overload In a Mouse Model Of β-Thalassemia Intermedia

Paul J Schmidt, PhD, Tim Racie, BS, Jim S Butler, PhD, Kevin Fitzgerald, PhD, Mark D Fleming, D.Phil., M.D.

Blood (2013) 122 (21): 1019.

https://doi.org/10.1182/blood.V122.21.1019.1019

Published: 2013

Journal Articles

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia

Paul J. Schmidt, Iva Toudjarska, Anoop K. Sendamarai, Tim Racie, Stuart Milstein, Brian R. Bettencourt, Julia Hettinger, David Bumcrot, Mark D. Fleming

Blood (2013) 121 (7): 1200–1208.

https://doi.org/10.1182/blood-2012-09-453977

Published: 2013

Includes: Supplemental data

Journal Articles

RNAi-Mediated Inhibition of Tmprss6 Ameliorates Anemia and Secondary Iron Overload in a Mouse Model of β-Thalassemia Intermedia and Decreases Iron Overload in Hfe −/− Mice

Paul J Schmidt, PhD, Anoop K Sendamarai, PhD, Ivanka Toudjarska, PhD, Tim Racie, Jim S Butler, PhD, Mark D. Fleming, MD, DPhil, David Bumcrot, PhD

Blood (2012) 120 (21): 1018.

https://doi.org/10.1182/blood.V120.21.1018.1018

Published: 2012

Journal Articles

Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin

Paul J. Schmidt, Nancy C. Andrews, Mark D. Fleming

Blood (2010) 116 (25): 5679–5687.

https://doi.org/10.1182/blood-2010-04-277954

Published: 2010

Includes: Supplemental data

Journal Articles

Hepcidin Expression Is Regulated by a Complex of Hemochromatosis-Associated Proteins.

Paul J. Schmidt, PhD, Franklin W. Huang, BA, Diedra M. Wrighting, BS, Paul T. Toran, BS, Nancy C. Andrews, MD, PhD

Blood (2006) 108 (11): 267.

https://doi.org/10.1182/blood.V108.11.267.267

Published: 2006

Journal Articles

Erythroid Homograft Following Leukocyte Transfusion in a Patient with Acute Leukemia : II. Serologic and Immunochemical Studies

PAUL J. SCHMIDT, M.D., MITSUO YOKOYAMA, M.D., MARY H. MCGINNISS, A.B., ROBERT H. LEVIN, M.D.

Blood (1965) 26 (5): 597–609.

https://doi.org/10.1182/blood.V26.5.597.597

Published: 1965

Journal Articles

The Antigenicity of the Rh o (D u ) Blood Factor

PAUL J. SCHMIDT, M.D., ELEANOR C. MORRISON, B.A., JANE SHOHL, M.D.

Blood (1962) 20 (2): 196–202.

https://doi.org/10.1182/blood.V20.2.196.196

Published: 1962

NARROW

Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine

Bitopertin, a Selective Glycine Transporter 1 Inhibitor, Reduced Protoporphyrin IX (PPIX) Level and Improved Liver Fibrosis in a Mouse Model of Erythropoietic Protoporphyria (EPP)

Pyridoxine Response in Mouse Alas2 Knock-in Models of X-Linked Sideroblastic Anemia and X-Linked Protoporphyria

A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

A Novel Conditional Knockout of the Diamond Blackfan Anemia Gene Rpl11 Shows Failure of Erythropoiesis, a Marked Increase in BFU-E Progenitors By Phenotype That Proliferate Poorly in Culture, and Activation of p53 Target Genes

Mutant Splicing Factor 3b Subunit 1 (SF3B1) Causes Dysregulated Erythropoiesis and a Stem Cell Disadvantage

HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression

An RNAi-Therapeutic Targeting Tmprss6, in Conjunction With Oral Chelator Therapy, Ameliorates Anemia and Additively Diminishes Secondary Iron Overload In a Mouse Model Of β-Thalassemia Intermedia

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia

RNAi-Mediated Inhibition of Tmprss6 Ameliorates Anemia and Secondary Iron Overload in a Mouse Model of β-Thalassemia Intermedia and Decreases Iron Overload in Hfe −/− Mice

Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin

Hepcidin Expression Is Regulated by a Complex of Hemochromatosis-Associated Proteins.

Erythroid Homograft Following Leukocyte Transfusion in a Patient with Acute Leukemia : II. Serologic and Immunochemical Studies

The Antigenicity of the Rh o (D u ) Blood Factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only